These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1818486)

  • 1. PAF and TNF alpha interactions in the pathophysiology of septic shock.
    Rabinovici R; Yue TL; Vernick J; Feuerstein G
    Adv Exp Med Biol; 1991; 314():193-203. PubMed ID: 1818486
    [No Abstract]   [Full Text] [Related]  

  • 2. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils.
    Chang SW
    Clin Res; 1992 Oct; 40(3):528-36. PubMed ID: 1395440
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS).
    Braquet P; Hosford D
    Prog Clin Biol Res; 1989; 308():425-39. PubMed ID: 2675060
    [No Abstract]   [Full Text] [Related]  

  • 4. Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome.
    Tracey KJ; Lowry SF; Cerami A
    Am Rev Respir Dis; 1988 Dec; 138(6):1377-9. PubMed ID: 3059894
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
    Sun XM; Hsueh W; Torre-Amione G
    Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor.
    Caplan MS; Hsueh W
    J Pediatr; 1990 Jul; 117(1 Pt 2):S47-51. PubMed ID: 2194011
    [No Abstract]   [Full Text] [Related]  

  • 8. Endotoxin-resistant mice are protected from PAF-induced bowel injury and death. Role of TNF, complement activation, and endogenous PAF production.
    Sun X; Caplan MS; Liu Y; Hsueh W
    Dig Dis Sci; 1995 Mar; 40(3):495-502. PubMed ID: 7895533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice.
    Myers AK; Robey JW; Price RM
    Br J Pharmacol; 1990 Mar; 99(3):499-502. PubMed ID: 2110016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages regulate the host response to bacterial lipopolysaccharides.
    Ulevitch RJ; Wolfson N; Virca GD; Kim S; Kline L; Mathison JC
    Prog Clin Biol Res; 1989; 299():193-202. PubMed ID: 2726979
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin.
    Ferguson-Chanowitz KM; Katocs AS; Pickett WC; Kaplan JB; Sass PM; Oronsky AL; Kerwar SS
    J Infect Dis; 1990 Nov; 162(5):1081-6. PubMed ID: 2230235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO; Letts G; Meade CJ
    J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
    Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
    Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The common mediator of shock, cachexia, and tumor necrosis.
    Beutler B; Cerami A
    Adv Immunol; 1988; 42():213-31. PubMed ID: 2834923
    [No Abstract]   [Full Text] [Related]  

  • 17. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
    Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
    Prog Clin Biol Res; 1989; 308():485-9. PubMed ID: 2780710
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of PAF and cytokines in microvascular tissue injury.
    Koltai M; Hosford D; Braquet P
    J Lab Clin Med; 1992 May; 119(5):461-6. PubMed ID: 1316420
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis.
    Hsueh W; Caplan MS; Sun X; Tan X; MacKendrick W; Gonzalez-Crussi F
    Acta Paediatr Suppl; 1994; 396():11-7. PubMed ID: 8086673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats.
    Rabinovici R; Bugelski PJ; Esser KM; Hillegass LM; Vernick J; Feuerstein G
    J Appl Physiol (1985); 1993 Apr; 74(4):1791-802. PubMed ID: 8514698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.